FOXO forms acquisition subsidiary, issues preferred stock, appoints CEO as interim CFO after CFO death

FOXO TECHNOLOGIES INC.

Formed FOXO Acquisition Corp., a wholly-owned subsidiary for healthcare services acquisitions; plans to create publicly listed non-convertible preferred stock for funding.
Appointed CEO Seamus Lagan as interim CFO after Martin Ward passed away on June 9, 2025; search for permanent CFO underway.
Amended exchange agreement with Smithline Family Trust II, increasing potential rights shares from 1.31M to 5.15M post-split; $384,297 debt remains.
Approximately $384,297 still owed to Smithline under Nov 2023 settlement; could require ~1.8M shares to settle at current price.
The new preferred stock is intended to be non-dilutive to common stockholders and generate cash/common stock dividends.

item 1.01item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Martin Ward

Interim Chief Financial Officer

FOXO · FOXO TECHNOLOGIES INC.

Effective: 2025-06-09
Successor: Seamus Lagan
Filed: Jun 13, 2025 23:59 UTC

On June 9, 2025, Martin Ward, the Company’s Interim Chief Financial Officer passed away unexpectedly.

Appointed (interim)

Seamus Lagan

Interim Chief Financial Officer

FOXO · FOXO TECHNOLOGIES INC.

Effective: 2025-06-13
Filed: Jun 13, 2025 23:59 UTC

On June 13, 2025, the Board of Directors of the Company (with Mr. Lagan abstaining) appointed Seamus Lagan to serve as the Company’s Interim Chief Financial Officer.

Source: SEC EDGAR

accession 0001641172-25-015132

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.